Tjalf Ziemssen
AuthID: R-00F-FP7
1
TÃTULO: Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study
AUTORES: Tjalf Ziemssen; Ann D Bass; Regina Berkovich; Giancarlo Comi; Sara Eichau; Jeremy Hobart; Samuel F Hunter; Christopher LaGanke; Volker Limmroth; Daniel Pelletier; Carlo Pozzilli; Sven Schippling; Livia Sousa; Anthony Traboulsee; Bernard M J Uitdehaag; Bart Van Wijmeersch; Zia Choudhry; Nadia Daizadeh; Barry A Singer;
PUBLICAÇÃO: 2020, FONTE: CNS DRUGS, VOLUME: 34, NÚMERO: 9
AUTORES: Tjalf Ziemssen; Ann D Bass; Regina Berkovich; Giancarlo Comi; Sara Eichau; Jeremy Hobart; Samuel F Hunter; Christopher LaGanke; Volker Limmroth; Daniel Pelletier; Carlo Pozzilli; Sven Schippling; Livia Sousa; Anthony Traboulsee; Bernard M J Uitdehaag; Bart Van Wijmeersch; Zia Choudhry; Nadia Daizadeh; Barry A Singer;
PUBLICAÇÃO: 2020, FONTE: CNS DRUGS, VOLUME: 34, NÚMERO: 9
INDEXADO EM: 
Scopus 
WOS
Scopus WOS2
TÃTULO: Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
AUTORES: William W L Brown; Alasdair Coles; Dana Horakova; Eva Havrdova; Guillermo Izquierdo; Alexandre Prat; Marc Girard; Pierre Duquette; Maria Trojano; Alessandra Lugaresi; Roberto Bergamaschi; Pierre Grammond; Raed Alroughani; Raymond Hupperts; Pamela McCombe; Vincent Van Pesch; Patrizia Sola; Diana Ferraro; Francois Grand'Maison; Murat Terzi; ...Mais
PUBLICAÇÃO: 2019, FONTE: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, VOLUME: 321, NÚMERO: 2
AUTORES: William W L Brown; Alasdair Coles; Dana Horakova; Eva Havrdova; Guillermo Izquierdo; Alexandre Prat; Marc Girard; Pierre Duquette; Maria Trojano; Alessandra Lugaresi; Roberto Bergamaschi; Pierre Grammond; Raed Alroughani; Raymond Hupperts; Pamela McCombe; Vincent Van Pesch; Patrizia Sola; Diana Ferraro; Francois Grand'Maison; Murat Terzi; ...Mais
PUBLICAÇÃO: 2019, FONTE: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, VOLUME: 321, NÚMERO: 2
INDEXADO EM: WOS
WOS3
TÃTULO: Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting
AUTORES: Philipp Albrecht; Ingrid Kristine Bjorna; David Brassat; Rachel Farrell; Peter Feys; Jeremy Hobart; Raymond Hupperts; Michael Linnebank; Jozef Magdic; Celia Oreja Guevara; Carlo Pozzilli; Antonio Vasco Salgado; Tjalf Ziemssen;
PUBLICAÇÃO: 2018, FONTE: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, VOLUME: 11
AUTORES: Philipp Albrecht; Ingrid Kristine Bjorna; David Brassat; Rachel Farrell; Peter Feys; Jeremy Hobart; Raymond Hupperts; Michael Linnebank; Jozef Magdic; Celia Oreja Guevara; Carlo Pozzilli; Antonio Vasco Salgado; Tjalf Ziemssen;
PUBLICAÇÃO: 2018, FONTE: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, VOLUME: 11
INDEXADO EM: Scopus WOS
Scopus WOS4
TÃTULO: Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial (J Neurol, (2014), 261, (2101-2111), 10.1007/s00415-014-7446-0)
AUTORES: Ziemssen, T; Bajenaru, OA; Carrá, A; de Klippel, N; Correia de Sá, J; Edland, A; Frederiksen, JL; Heinzlef, O; Karageorgiou, KE; Lander Delgado, RH; Landtblom, AM; Macías Islas, MA; Tubridy, N; Gilgun Sherki, Y;
PUBLICAÇÃO: 2015, FONTE: Journal of Neurology, VOLUME: 262, NÚMERO: 1
AUTORES: Ziemssen, T; Bajenaru, OA; Carrá, A; de Klippel, N; Correia de Sá, J; Edland, A; Frederiksen, JL; Heinzlef, O; Karageorgiou, KE; Lander Delgado, RH; Landtblom, AM; Macías Islas, MA; Tubridy, N; Gilgun Sherki, Y;
PUBLICAÇÃO: 2015, FONTE: Journal of Neurology, VOLUME: 262, NÚMERO: 1
INDEXADO EM: Scopus
Scopus5
TÃTULO: COPTIMIZE: a two-year observational survey of patients with relapsing remitting multiple sclerosis switching to glatiramer acetate 20 mg daily Full Text
AUTORES: Ziemssen, T; Bajenaru, O; Carra, A; de Klippel, N; de Sa, J; Edland, A; Frederiksen, J; Heinzlef, O; Karageorgiou, K; Landtblom, AM; Macias Islas, MM; Tubridy, N; Gilgun Sherki, Y;
PUBLICAÇÃO: 2013, FONTE: 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS in MULTIPLE SCLEROSIS JOURNAL, VOLUME: 19, NÚMERO: 11
AUTORES: Ziemssen, T; Bajenaru, O; Carra, A; de Klippel, N; de Sa, J; Edland, A; Frederiksen, J; Heinzlef, O; Karageorgiou, K; Landtblom, AM; Macias Islas, MM; Tubridy, N; Gilgun Sherki, Y;
PUBLICAÇÃO: 2013, FONTE: 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS in MULTIPLE SCLEROSIS JOURNAL, VOLUME: 19, NÚMERO: 11
INDEXADO EM: WOS
WOS